← Home / XTL BIOPHARMACEUTICALS LTD. (XTLB)
Stock Analysis
XTL BIOPHARMACEUTICALS LTD. (XTLB)
XTLB
XTLB · Market data
2.91 +0.69%
52W Range Position
14%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-07-12 19:54 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 3.30. Holding above 2.67 keeps the current thesis intact.
⚖️
✓
Fundamentals
Insufficient / Negative
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
2.67
↗
Break Above
Confirmation improves above resistance.
3.30
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 2.67
What's Driving XTLB?
📈 Technical recovery is improving
Momentum is Neutral. Watch 3.30 for confirmation and 2.67 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 2.67
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
DT Break
fresh (age 4)
RSI(14)
57.2
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 2.64 and resistance at 2.96. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
XTLB · WOI overlay chart
Open Full Workspace
Business Lens
Financial pressure is elevated
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Manageable
💵 Revenue
451,000
≈ Insufficient
📈 Net Income
-1.03M
↘ Negative
🧮 EPS (Basic)
-0.00
↘ Negative
XTL BIOPHARMACEUTICALS LTD.
Related Opportunities